FORMULATION COMPLEXE CONTENANT DE LA METFORMINE À LIBÉRATION PROLONGÉE ET UN INHIBITEUR DE LA HMG-COA RÉDUCTASE À LIBÉRATION IMMÉDIATE

• 收藏
• 分享

专利权人:

CJ Healthcare Corporation

发明人:

申请号：

EP14828739.4

公开号：

EP3025708B1

申请日:

2014.07.25

申请国别(地区):

EP

年份:

2017

代理人:

摘要：

The present invention relates to a combination formulation containing metformin for treating non-insulin-dependent diabetes and an HMG-CoA reductase inhibitor for treating dyslipidemia. The present invention provides a combination formulation and a method for preparing the combination formulation, wherein the combination formulation contains metformin and an HMG-CoA reductase inhibitor, and has effectively improved stability by blocking physical and chemical reactions between the active ingredients while securing the stable release of respective active ingredients.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/